> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Since Our Last Issue ...
- URL: https://www.fdaweb.com/since-our-last-issue-110/
- Published: 2018-07-15T12:00:00.000Z
- Updated: 2026-09-15T00:19:25.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141705

**American Diversified Holdings** has acquired Houston-based **Brazos Biomedical**. The transaction gives American Diversified the AURACIS TENS Migraine therapy system, including all patents and patent applications in the U.S. and abroad, patent license agreements, technical engineering schematics, FDA plans, patient study information and other related assets.

**LabCorp** has acquired **Sciformix**, a scientific process outsourcing company focused on pharmacovigilance and regulatory solutions for biopharmaceutical and medical devices clients. Sciformix will become part of **Covance**, LabCorp’s drug development business.

**Boston Scientific** has agreed to acquire **NxThera**, a privately-held company based in Maple Grove, MN for $306 million upfront and an additional $100 million in potential commercial milestone payments over the next four years. The transaction gives Boston Scientific the Rezum, a treatment system for men with symptoms arising from benign prostatic hyperplasia.